Brain CT and MR Findings in Hyperphenylalaninemia due to Dihydropteridine Reductase Deficiency (Variant of Phenylketonuria)
- 1 September 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 14 (5) , 699-703
- https://doi.org/10.1097/00004728-199009000-00003
Abstract
Two siblings with malignant hyperphenylalaninemia were examined by magnetic resonance (MR) imaging and CT of the brain. Both techniques demonstrated diffuse cerebral atrophy and cystic loss of parenchyma with surrounding white matter changes. T2-weighted MR images demonstrated the white matter changes better than CT. However, MR images gave no definite indication of the presence of calcification, and CT demonstrated the characteristic calcifications in the basal ganglia and subcortical region bilaterally. Both MR and CT are complementary in the evaluation of this disease.This publication has 9 references indexed in Scilit:
- MR DETECTION OF INTRACRANIAL CALCIFICATION - A PHANTOM STUDY1987
- MR imaging of calcified intracranial lesions.Radiology, 1985
- Cranial computerized tomography in dihydropteridine reductase deficiencyJournal of Inherited Metabolic Disease, 1985
- Morphologic and histoanatomic observations of the brain in untreated human phenylketonuriaActa Neuropathologica, 1982
- CRANIAL COMPUTERIZED TOMOGRAPHY IN PHENYLKETONURIA1Neuropediatrics, 1981
- Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: Biochemical and pathological findings.The Tohoku Journal of Experimental Medicine, 1980
- Malignant Hyperphenylalaninemia—Clinical Features, Biochemical Findings, and Experience with Administration of BiopterinsPediatric Research, 1979
- The phenylalanine hydroxylating system in phenylketonuria and its variantsBiochemical Medicine, 1976